Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 1, 2003, Pages 34-41

  Ravna, Aina Westrheim ^a   Sylte, Ingebrigt ^a   Dahl, Svein G ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; COCAINE; COTRANSPORTER; DOPAMINE TRANSPORTER; NEUROTRANSMITTER; NORADRENALIN TRANSPORTER; PHENYLALANINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; DIPOLE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ENANTIOMER; ESCHERICHIA COLI; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STEREOCHEMISTRY;

ANIMALS; BINDING SITES; CARRIER PROTEINS; CITALOPRAM; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN STRUCTURE, TERTIARY; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS;

EID: 0141519516     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.054593     Document Type: Article

References (40)

1. Adkins EM, Barker EL, and Blakely RD (2001) Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Mol Pharmacol 59:514-523.
2. Akunne HC, de Costa BR, Jacobson AE, Rice KC, and Rothman RB (1992) [3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine. Neurochem Res 17:1275-1283.
3. Bairoch A and Apweiler R (1999) The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999. Nucleic Acids Res 27:49-54.
4. Barker EL and Blakely RD (1995). Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 321-334, Raven Press, New York.
5. Barker EL, Moore KR, Rakhshan F, and Blakely RD (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717.
6. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, and Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem 273:19459-19468.
7. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, and Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242.
8. Chang G and Roth CB (2001) Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science (Wash DC) 293:1793-1800.
9. Chen JG, Liu-Chen S, and Rudnick G (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 273:12675-12681.
10. Chen JG, Sachpatzidis A, and Rudnick G (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327.
11. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, and Kollman PA (1995) A 2nd generation force-field for the simulation of proteins, nucleic-acids and organic-molecules. J Am Chem Soc 117:5179-5197.
12. Ferrin TE, Huang CC, Jarvis LE, and Langridge R (1988) The MIDAS display system. J Mol Graphics 6:13.
13. Hibert MF, Trumpp-Kallmeyer S, Bruinvels A, and Hoflack J (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol 40:8-15.
14. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 (Suppl 1):19-26.
15. Kaback HR and Wu J (1997) From membrane to molecule to the third amino acid from the left with a membrane transport protein. Q Rev Biophys 30:333-364.
16. + and methanethiosulfonate reagents. J Biol Chem 276:4038-4045.
17. Karplus M and McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9:646-652.
18. Kitayama S, Morita K, Dohi T, Wang JB, Davis SC, and Uhl GR (1996) Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells. Ann N Y Acad Sci 801:388-393.
19. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, and Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785.
20. Larsen NA, Turner JM, Stevens J, Rosser SJ, Basran A, Lerner RA, Bruce NC, and Wilson IA (2002) Crystal structure of a bacterial cocaine esterase. Nat Struct Biol 9:17-21.
21. Lee SH, Chang MY, Lee KH, Park BS, Lee YS, and Chin HR (2000) Importance of valine at position 152 for the substrate transport and 2β -carbomethoxy-3β-(4-fluorophenyl)tropane binding of dopamine transporter. Mol Pharmacol 57:883-889.
22. Lin Z, Wang W, Kopajtic T, Revay RS, and Uhl GR (1999) Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Mol Pharmacol 56:434-447.
23. Mitsuhata C, Kitayama S, Morita K, Vandenbergh D, Uhl GR, and Dohi T (1998) Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine. Brain Res Mol Brain Res 56:84-88.
24. Mortensen OV, Kristensen AS, and Wiborg O (2001) Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants. J Neurochem 79:237-247.
25. Murakami S, Nakashima R, Yamashita E, and Yamaguchi A (2002) Crystal structure of bacterial multidrug efflux transporter AcrB. Nature (Lond) 419:587-593.
26. Owens MJ, Knight DL, and Nemeroff CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50:345-350.
27. Paczkowski FA and Bryan-Lluka LJ (2001) Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology. Brain Res Mol Brain Res 97:32-42.
28. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, and Miyano M (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
29. Penado KM, Rudnick G, and Stephan MM (1998) Critical amino acid residues in transmembrane span 7 of the serotonin transporter identified by random mutagenesis. J Biol Chem 273:28098-28106.
30. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, and Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
31. Rasmussen SG, Carroll FI, Maresch MJ, Jensen AD, Tate CG, and Gether U (2001) Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter. J Biol Chem 276:4717-4723.
32. Ravna AW and Edvardsen O (2001) A putative three-dimensional arrangement of the human serotonin transporter transmembrane helices: a tool to aid experimental studies. J Mol Graph Model 20:133-144.
33. + antiporter NhaA. Receptors and Channels 7:319-328.
34. Ravna AW, Sylte I, and Dahl SG (2003) Molecular model of the neural dopamine transporter. J Comput Aided Mol Des 7:319-328.
35. Reizer J, Reizer A, and Saier MH Jr (1994) A functional superfamily of sodium/solute symporters. Biochim Biophys Acta 1197:133-166.
36. + antiporter from Escherichia coli. J Biol Chem 271:32288-32292.
37. Sur C, Betz H, and Schloss P (1998) Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1. J Neurochem 70:2545-2553.
38. 1A receptor. Eur J Pharmacol 416:33-41.
39. Tatsumi M, Groshan K, Blakely RD, and Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
40. Williams KA (2000) Three-dimensional structure of the ion-coupled transport protein NhaA. Nature (Lond) 403:112-115.